[1] Torre L A, Bray F, Siegel R L,et al. Global cancer statistics, 2012[J].CA Cancer J Clin,2015,65(2):87
[2] Cho A, Jo K, Hwang S H,et al. Correlation between KRAS mutation and 18F-FDG uptake in stage IV colorectal cancer[J]. Abdom Radiol (NY), 2017, 42(6):1621
[3] Zhan X, Sun X, Hong Y,et al. Combined detection of preoperative neutrophil-to-lymphocyte ratio and CEA as an independent prognostic factor in nonmetastatic patients undergoing colorectal cancer resection is superior to NLR or CEA Alone[J]. Biomed Res Int,2017,2017(5):3809464
[4] Ye Y, Liu T, Lu L, et al. Pre-operative TNM staging of primary colorectal cancer by (18)F-FDG PET-CT or PET: a meta-analysis including 2283 patients[J]. Int J Clin Exp Med, 2015, 8(11):21773
[5] Zaidi H, Karakatsanis N.Towards enhanced PET quantification in clinical oncology[J]. Br J Radiol, 2018,91(1081):20170508
[6] Wang X Y, Zhao Y F, Liu Y, et al. Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma[J]. Medicine (Baltimore), 2017,96(35):e7941
[7] Zhang L, Sun H, Du S,et al.Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer[J]. Nucl Med Commun, 2018, 39(11):1045
[8] Brenner H, Kloor M, Pox C P.Colorectalcancer[J]. Lancet, 2014,383(9927):1490
[9] 易呈浩,葛维挺,黄彦钦, 等.1368例结直肠癌TNM分期及预后分析[J].中国肿瘤临床,2012,(9):597
[10] Yu L, Tian M, Gao X,et al.The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma[J].Acad Radiol, 2012,19(4):427
[11] Suzuki Y, Okabayashi K, Hasegawa H, et al. Metabolic tumor volume and total lesion glycolysis in PET/CT correlate with the pathological findings of colorectal cancer and allow its accurate staging[J]. Clin Nucl Med, 2016, 41(10):761
[12] Ogawa S, Itabashi M, Kondo C,et al. Prognostic value of total lesion glycolysis measured by 18F-FDG-PET/CT in patients with colorectal cancer[J]. Anticancer Res, 2015, 35(6):3495
[13] Nakajo M, Kajiya Y, Tani A,et al. A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery[J]. Eur J Nucl Med Mol Imaging, 2017,44(13):2158
[14] Vanderhoek M, Perlman S B, Jeraj R.Impact of the definition of peak standardized uptake value on quantification of treatment response[J]. J Nucl Med, 2012,53(1):4
[15] Jo H J, Kim S J, Lee H Y,et al. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer[J].Clin Nucl Med, 2014,39(6):493
[16] Xu J, Li Y, Hu S, et al. The significant value of predicting prognosis in patients with colorectal cancer using 18F-FDG PET metabolic parameters of primary tumors and hematological parameters[J]. Ann Nucl Med, 2019, 33(1):32
[17] 丁重阳, 李天女,郭喆, 等.18氟-氟代脱氧葡萄糖PET/CT检查判断结直肠癌术后预后的临床价值[J].中华消化外科杂志, 2016(10):1018
[1]季艳会,谭 建,张桂芝,等.全身广泛骨转移为首发症状的甲状腺微小乳头状癌1例[J].天津医科大学学报,2015,21(04):314.
[2]周 雯,朱 湘,王 健,等.18F-FDG PET/CT显像在食管癌分期时发现同时性重复癌的价值[J].天津医科大学学报,2015,21(05):404.
ZHOU Wen,ZHU Xiang,WANG Jian,et al. 18F-FDG PET/CT in detecting synchronous primary neoplasms for initial stage of esophageal cancer[J].Journal of Tianjin Medical University,2015,21(04):404.
[3]刘 龙,赵景旺,陈旨娟,等.探讨胶质母细胞瘤病变范围在MRI增强和MET-PET中的差异性[J].天津医科大学学报,2017,23(01):32.
LIU Long,ZHAO Jing-wang,CHEN Zhi-juan,et al.Differece between methionine PET and MR enhancement in? the range of glioblastoma multiforme[J].Journal of Tianjin Medical University,2017,23(04):32.